Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00473200 · ClinicalTrials.gov registry record · Phase 1
Effect of S-adenosylmethionine (SAMe) on Blood Levels of Homocysteine
A Phase 1 study, sponsored by Baylor Research Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 27
- Enrollment target
NCT00473200 is a Phase 1 study that has completed, run by Baylor Research Institute. The registered enrollment target is 27 participants.
The verdict
NCT00473200, a Phase 1 study, has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 27 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate whether S-adenosylmethionine (SAMe), a natural substance available as a nutritional supplement, can influence blood levels of homocysteine (Hcy). More specifically, we will determine if chronic oral SAMe administration affects homocysteine metabolism in patients with vascular disease who have mild to moderate hyperhomocysteinemia.
Interventions
- DIETARY_SUPPLEMENT S-adenosylmethionine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2009-08 |
| Est. Completion | 2013-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00473200
The ClinicalTrials.gov registry entry for NCT00473200 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which S-adenosylmethionine is the first listed.
NCT00473200 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00473200 about?
NCT00473200 is a clinical study titled "Effect of S-adenosylmethionine (SAMe) on Blood Levels of Homocysteine". The purpose of this study is to investigate whether S-adenosylmethionine (SAMe), a natural substance available as a nutritional supplement, can influence blood levels of homocysteine (Hcy). More specifically, we will determine if chronic oral SAMe administration affects homocysteine metabolism in pa...
What is the current status of trial NCT00473200?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 27 participants. The study started on 2009-08. Estimated completion is 2013-07.
What interventions are being tested in trial NCT00473200?
The interventions under investigation include: S-adenosylmethionine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00473200?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.